De Burlo Group’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

De Burlo Group’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-39,800	Closed	-$16K	–	121
2018 Q1	$16K	Hold	39,800	–	–	﹤0.01%	103
2017 Q4	$15K	Hold	39,800	–	–	﹤0.01%	107
2017 Q3	$14K	Hold	39,800	–	–	﹤0.01%	105
2017 Q2	$15K	Hold	39,800	–	–	﹤0.01%	101
2017 Q1	$17K	Hold	39,800	–	–	﹤0.01%	101
2016 Q4	$15K	Hold	39,800	–	–	﹤0.01%	95
2016 Q3	$10K	Buy	+39,800	New	+$10.1K	﹤0.01%	98
2016 Q1	–	Sell	-39,800	Closed	-$4K	–	110
2015 Q4	$4K	Buy	+39,800	New	+$5.62K	﹤0.01%	102
2015 Q2	–	Sell	-39,800	Closed	-$26K	–	113
2015 Q1	$26K	Hold	39,800	–	–	0.01%	101
2014 Q4	$31K	Hold	39,800	–	–	0.01%	107
2014 Q3	$19K	Sell	39,800 -500	-1%	-$243	﹤0.01%	103
2014 Q2	$20K	Hold	40,300	–	–	﹤0.01%	99
2014 Q1	$13K	Buy	+40,300	New	+$15K	﹤0.01%	95
2013 Q4	–	Sell	-40,300	Closed	-$81K	–	110
2013 Q3	$81K	Sell	40,300 -100	-0.2%	-$190	0.02%	98
2013 Q2	$77K	Buy	+40,400	New	+$71K	0.02%	92

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

De Burlo Group's GCVRZ Position: Q2 2018 in Review

De Burlo Group sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2018, closing a stake of 39,800 shares — an estimated $16K sold.

De Burlo Group first reported a position in GCVRZ in Q2 2013 and held it in 15 quarters. The position peaked at $81K in Q3 2013. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2018.

De Burlo Group reported no remaining Sanofi Contingent Value Rights position as of Q2 2018 after selling out during the quarter.
De Burlo Group sold 39,800 Sanofi Contingent Value Rights shares in Q2 2018, an estimated $16K.
De Burlo Group first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 15 quarters.
De Burlo Group's Sanofi Contingent Value Rights position peaked at $81K in Q3 2013.
106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2018.

Based on De Burlo Group's 13F filing for Q2 2018, filed 10 Aug 2018.